Literature DB >> 27224726

Molecular correlates and prognostic value of tmTNF-α expression in colorectal cancer of 5-Fluorouracil-Based Adjuvant Therapy.

Xiaogai Li1, Shihai Wang2, HuiJun Ren1, Junfen Ma1, Xiaoxu Sun1, Nan Li1, Cailin Liu1, Kaida Huang1, Min Xu1, Liang Ming1.   

Abstract

Transmembrane tumor necrosis factor-α (tmTNF-α) is known to induce the activation of NF-κB to protect tumor cells. Upregulation of tmTNF-α leads to resistance to apoptosis and induces drug resistance in breast cancer. However, the expression of tmTNF-α in colorectal cancer (CRC) and its association with clinical outcome in CRC have remained unclear. In this study, we examined the tmTNF-α expression in CRC by immunohistochemistry and western blotting, assessed the prognostic value of tmTNF-α related to the recurrence/metastasis and survival of stage II/III CRC by the Kaplan-Meier survival curve and Cox regression model, and also explored the role of tmTNF-α expression on the chemotherapeutic efficacy of 5-Fluorouracil by flow cytometry assay and cell counting kit-8 (CCK-8) in vitro. Overall, we found that 77 (78.6%) out of 98 patients exhibited higher tmTNF-α expression in the CRC tissues comparing with the adjacent tissues. The tmTNF-α expression was correlated with Differentiation (P = 0.019), TNM stage (P = 0.039), Lymph nodes metastasis (P = 0.024) and Lymphovascular invasion (P = 0.027) but not related with Age (P = 0.617), Gender (P = 0.625), Tumor location (P = 0.138), Perforation/Obstruction (P = 1.000), Depth of invasion (P = 0.327), and microsatellite instability status (P = 0.150). The prognostic analyses showed that high tmTNF-α expression patients was significantly associated with decreased Disease-Free Survival (P = 0.0209) and Overall Survival (P = 0.0163). CCK-8 results suggested that the tmTNF-α influenced the chemotherapeutic effect of 5-Fluorouracil on colon cancer cells. Altogether, these data indicated the stageII/III CRC patients with high tmTNF-α expression were more likely to have a worse prognosis than patients with low tmTNF-α expression and tmTNF-α may influence the chemotherapeutic effect of 5-Fluorouracil. The mechanism for these observations warrants further study.

Entities:  

Keywords:  Colorectal cancer; prognosis; recurrence/metastasis; survival; tmTNF-α

Mesh:

Substances:

Year:  2016        PMID: 27224726      PMCID: PMC4990407          DOI: 10.1080/15384047.2016.1187551

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  40 in total

1.  The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.

Authors:  Sung Pil Hong; Byung So Min; Tae Il Kim; Jae Hee Cheon; Nam Kyu Kim; Hoguen Kim; Won Ho Kim
Journal:  Eur J Cancer       Date:  2011-11-07       Impact factor: 9.162

2.  Transmembrane TNF-alpha mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-kappaB pathway in Raji Burkitt lymphoma cells.

Authors:  Hailong Zhang; Dan Yan; Xu Shi; Huifang Liang; Yan Pang; Nalin Qin; Hui Chen; Jing Wang; Bingjiao Yin; Xiaodan Jiang; Wei Feng; Wenjie Zhang; Muxiang Zhou; Zhuoya Li
Journal:  J Leukoc Biol       Date:  2008-06-11       Impact factor: 4.962

3.  Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.

Authors:  Yongmei Yin; Xiaofeng Chen; Yongqian Shu
Journal:  Biomed Pharmacother       Date:  2009-06-13       Impact factor: 6.529

4.  Targeting transmembrane TNF-α suppresses breast cancer growth.

Authors:  Mingxia Yu; Xiaoxi Zhou; Lin Niu; Guohong Lin; Jin Huang; Wenjing Zhou; Hui Gan; Jing Wang; Xiaodan Jiang; Bingjiao Yin; Zhuoya Li
Journal:  Cancer Res       Date:  2013-06-21       Impact factor: 12.701

5.  Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer.

Authors:  Oktay Bozkurt; Mevlude Inanc; Esma Turkmen; Halit Karaca; Veli Berk; Ayse Ocak Duran; Ersin Ozaslan; Mahmut Ucar; Ilhan Hacibekiroglu; Baki Eker; Osman Baspinar; Metin Ozkan
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Improvement of supersensitive immunohistochemistry with an autostainer: a simplified catalysed signal amplification system.

Authors:  Kazuhisa Hasui; Tomio Takatsuka; Ryoichi Sakamoto; Liying Su; Sachie Matsushita; Shin-ichiro Tsuyama; Shuji Izumo; Fusayoshi Murata
Journal:  Histochem J       Date:  2002-05

Review 7.  Is it safe to use TNF-α blockers for systemic inflammatory disease in patients with heart failure? Importance of dosage and receptor specificity.

Authors:  Andreas P Diamantopoulos; Alf I Larsen; Roald Omdal
Journal:  Int J Cardiol       Date:  2012-12-14       Impact factor: 4.164

Review 8.  Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.

Authors:  Gaëtan Des Guetz; Olivier Schischmanoff; Patrick Nicolas; Gérard-Yves Perret; Jean-François Morere; Bernard Uzzan
Journal:  Eur J Cancer       Date:  2009-05-06       Impact factor: 9.162

9.  Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo.

Authors:  Qingfen Li; Li Li; Wenfang Shi; Xiaodan Jiang; Yong Xu; Feili Gong; Muxiang Zhou; Carl K Edwards; Zhuoya Li
Journal:  Cancer Immunol Immunother       Date:  2006-03-23       Impact factor: 6.968

10.  Analysis of tumor necrosis factor α-induced and nuclear factor κB-silenced LNCaP prostate cancer cells by RT-qPCR.

Authors:  Ceren Gonen-Korkmaz; Gulnur Sevin; Goksel Gokce; Mehmet Zuhuri Arun; Gokce Yildirim; Buket Reel; Aysegul Kaymak; Deniz Ogut
Journal:  Exp Ther Med       Date:  2014-10-17       Impact factor: 2.447

View more
  5 in total

1.  PIK3R3 promotes chemotherapeutic sensitivity of colorectal cancer through PIK3R3/NF-kB/TP pathway.

Authors:  Sidikjan Ibrahim; Guodong Li; Fuqing Hu; Zhenlin Hou; Qianzhi Chen; Geng Li; Xuelai Luo; Junbo Hu; Yongdong Feng
Journal:  Cancer Biol Ther       Date:  2018-01-25       Impact factor: 4.742

2.  TNF-α Modulates P-Glycoprotein Expression and Contributes to Cellular Proliferation via Extracellular Vesicles.

Authors:  Tandressa Berguetti; Lucas S P Quintaes; Thais Hancio; Marcela C Robaina; André L S Cruz; Raquel C Maia; Paloma Silva de Souza
Journal:  Cells       Date:  2019-05-24       Impact factor: 6.600

Review 3.  Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.

Authors:  María Florencia Mercogliano; Sofía Bruni; Florencia Mauro; Patricia Virginia Elizalde; Roxana Schillaci
Journal:  Cancers (Basel)       Date:  2021-02-02       Impact factor: 6.639

4.  Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer.

Authors:  Hongping Ba; Rui Jiang; Meng Zhang; Bingjiao Yin; Jing Wang; Zhuoya Li; Baihua Li; Xiaoxi Zhou
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

Review 5.  Targeting TNFR2 in Cancer: All Roads Lead to Rome.

Authors:  Jingchao Bai; Bowen Ding; Hui Li
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.